financetom
Business
financetom
/
Business
/
International Game Technology Stock Falls Despite Q2 EPS Beat; Revenue Misses Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
International Game Technology Stock Falls Despite Q2 EPS Beat; Revenue Misses Estimates
Jul 30, 2024 8:19 AM

International Game Technology ( IGT ) shares are trading lower after releasing results for the second quarter.

The company reported quarterly adjusted earnings per share of 36 cents, beating the analyst consensus of 32 cents.

Second-quarter revenues of $1.049 billion missed the street view of $1.059 billion, as strength in Gaming & Digital is offset by elevated prior year product sales in Global Lottery.

International Game Technology ( IGT ) said it generated over $460 million in cash from operations and over $260 million in free cash flow in the first half of the year.

Adjusted EBITDA was stable at $446 million, and Adjusted EBITDA margin expanded by 30 basis points.

Also Read: What’s Going On With Plug Power Stock Today?

The recently announced sale of our Gaming & Digital business for $4.05 billion in cash is an important step in unlocking the intrinsic value of IGT’s best-in-class businesses,” said Vince Sadusky, CEO.

Global Lottery revenue of $613 million decreased 2% year-over-year, primarily due to a multi-year software license sale in the prior year.

Gaming & Digital revenue of $436 million was up 1% versus the prior year.

Total liquidity of $1.7 billion as of June 30, 2024; $0.4 billion in unrestricted cash and $1.3 billion in additional borrowing capacity from undrawn credit facilities.

International Game Technology ( IGT ) declared a quarterly cash dividend of $0.20 per common share (payment date of Aug. 27, 2024).

Due to the planned sale of the Gaming & Digital business, the company expects to classify and report Gaming & Digital results as discontinued operations beginning in the third quarter of 2024.

As a result, International Game Technology ( IGT ) is withdrawing its previously provided full-year financial outlook.

Price Action: IGT shares are trading lower by 3.16% to $22.71 at last check Tuesday.

Read Next:

Melania Trump's New Memoir Promises Unseen Photos And Revelations Before Election

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Xiaomi Asks Indian Watchdog to Recall Antitrust Report on Walmart India Unit Flipkart
Market Chatter: Xiaomi Asks Indian Watchdog to Recall Antitrust Report on Walmart India Unit Flipkart
Oct 3, 2024
08:29 AM EDT, 09/23/2024 (MT Newswires) -- Chinese smartphone maker Xiaomi has asked the Competition Commission of India to recall its antitrust report, which found Xiaomi and Walmart's ( WMT ) India unit Flipkart in breach of competition laws, Reuters reported Monday, citing people familiar with the matter. Any recall of the commission's report could cause a delay in its...
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data
Exchange-Traded Funds, Equity Futures Edge Higher Pre-Bell Monday Ahead of Key Inflation Data
Oct 3, 2024
08:27 AM EDT, 09/23/2024 (MT Newswires) -- The broad market exchange-traded fund SPDR S&P 500 ETF Trust ( SPY ) was up 0.1% and the actively traded Invesco QQQ Trust (QQQ) was 0.2% higher in Monday's premarket activity, ahead of a key inflation data release due later in the week. US stock futures were also edging higher, with S&P 500...
UAE seeks closer AI, tech ties in Biden talks as China interest stirs US concern
UAE seeks closer AI, tech ties in Biden talks as China interest stirs US concern
Oct 3, 2024
* First time a UAE president visits White House * UAE ambitiously pursuing AI development * U.S. wary of UAE-China relationship By Alexander Cornwell DUBAI, Sept 23 (Reuters) - President Joe Biden will host the United Arab Emirates president on Monday for a visit set to include White House talks on the Gulf state's plans for artificial intelligence, an ambitious...
Zevra Therapeutics prices genetic disorder drug at up to $106,000 per month
Zevra Therapeutics prices genetic disorder drug at up to $106,000 per month
Oct 3, 2024
Sept 23 (Reuters) - Zevra Therapeutics' ( ZVRA ) drug, Miplyffa, for treating a rare and fatal genetic disorder will have a wholesale acquisition cost ranging between $40,000 and $106,000 per month depending on dosage, the company said on a conference call on Monday. The U.S. health regulator on Friday approved the drug making it the first treatment to get...
Copyright 2023-2026 - www.financetom.com All Rights Reserved